Arief Rahadian MD, graduated from Diponegoro University, Indonesia and continue his study as PhD at Tokushima University, Japan, in the Cardiovascular Department since 2017.
Glycemic control with canagliflozin, a SGLT-2 inhibitor, attenuates atherosclerosis and endothelial dysfunction in diabetic apolipoprotein e-deficient mice
